Will Prenetics stock go up?

According to Danelfin AI, Prenetics has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (49.22%) is -1.60% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Prenetics stock?

The Prenetics target price is $16.95 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Prenetics stock right now?

Prenetics has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (49.22%) is -1.60% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Prenetics stock is a good buy .

Is Prenetics undervalued right now?

Based on analysts, the average price target downside for Prenetics is 0.00% (1Y). According to Danelfin AI, Prenetics has today an AI Score of 4/10 (Hold Rating).

What was the price range of Prenetics stock over the past 12 months?

The Prenetics stock price range over the past 12 months has been $7.25 - $22.15.

What is going on with Prenetics stock in the last 3 months?

The Prenetics stock performance in the last quarter has been -13.38%.

Does Prenetics offer dividend payments?

No, Prenetics does not currently pay dividends.

What is the current market capitalization of Prenetics?

Prenetics's market cap is $284.9M, as of 2026-07-03 08:00.

Prenetics Global Ltd (PRE) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

PRE AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Earnings Quality+0.43%
Stability and reliability of reported earnings
Momentum+0.39%
Direction and strength of recent price movements
Size & Liquidity+0.25%
Company size and trading liquidity

Volatility-1.06%
How much the stock price tends to fluctuate
Sentiment-0.82%
How analysts and the market view the stock
Valuation-0.67%
How the stock is priced relative to its fundamentals
Growth-0.12%
Expected pace of revenue and earnings expansion

PRE probability advantage of beating the market (3M):

-1.60%

AI Score

Hold

Prenetics (PRE) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -1.60% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of PRE (49.22%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
PRE probability advantage of beating the market (3M)-1.60%
PRE probability of beating the market (3M)49.22%

PRE probability advantage of beating the market (3M): -1.60%

The AI-powered overall analysis of Prenetics (PRE) is based on the 27 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of PRE:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Technical	Chart Pattern (252d)	figure_42	N/A	+1.78%
Sentiment	Country	Hong Kong	N/A	+1.07%
Technical	Chart Pattern (504d)	figure_18	N/A	-0.94%
Sentiment	Institutional Ownership	9.77%		-0.81%
Technical	ATR (14d Volatility)	1.53		-0.75%
Technical	Chart Pattern (180d)	figure_138	N/A	-0.70%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	-0.62%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-0.58%
Fundamental	Basic EPS Consolidated	-1.36	N/A	-0.48%
Sentiment	Earnings Countdown	-16		+0.44%
Fundamental	Upgrade to unlock			+0.43%
Fundamental	Upgrade to unlock			-0.42%
Sentiment	Upgrade to unlock			-0.42%
Technical	Upgrade to unlock			+0.39%
Technical	Upgrade to unlock			+0.37%

Rest of Alpha Signals: -0.38%

PRE probability advantage of beating the market (3M)Total:-1.60%
PRE AI Score

Significant changes Vs previous day

PRE Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$16.95
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

PRE Proven Hold Signal & Price Forecast

This is the price chart for PRE from January 3, 2026 until today. The chart indicates, in yellow, the 0 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

PRE Average Past Performance & Win Rate

Three months after its 333 Hold signals since July 2026, PRE had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

333 Past PRE Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-40.07%
Average Alpha				-60.87%
Win Rate (% Positive Perf.)				15.02%
% Positive Alpha				4.69%

PRE Frequently Asked Questions

Will Prenetics stock go up?
According to Danelfin AI, Prenetics has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (49.22%) is -1.60% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Prenetics stock?
Is it a good time to buy, sell, or hold Prenetics stock right now?
Is Prenetics undervalued right now?
What was the price range of Prenetics stock over the past 12 months?
What is going on with Prenetics stock in the last 3 months?
Does Prenetics offer dividend payments?
What is the current market capitalization of Prenetics?

Prenetics Global Ltd Company Profile

Prenetics Global Limited, with operations in Hong Kong and the United Kingdom, is a company specializing in diagnostics and genetic testing. Its product portfolio includes CircleDNA, a consumer-focused genetic assessment tool, and the Circle HealthPod—rapid-response health monitoring equipment designed for professional and home use, notably providing COVID-19 testing solutions.

The company has also developed ColoClear, an innovative FIT-DNA colorectal cancer screening system that offers non-invasive testing capabilities. Additionally, it provides the Circle SnapShot—an easy-to-use at-home blood exam—and ACTOnco a comprehensive diagnostic tool assisting medical professionals in streamlining treatment options for significant solid tumors.

Furthermore, Prenetics offers ACTDrug+, a crucial screening solution that analyzes 40 different cancer-related genes to outline potential medication choices and define treatment strategies. The firm also focuses on diseases like lung cancer with specialized tests such as ACTLung. It also provides ACTFusion, which interprets 13 fusion genes and over 350 transcripts to establish medication possibilities.

Its cutting-edge service—ACTCerebra—undertakes genomic profiling of solid tumors. Moreover, they offer two other key tests: The ACTMonitor which examines 50 types of circulating tumor DNA present in our bloodstream; and the ACT Risk—a preemptive screen that identifies mutations found within 67 cancer genes linked with nine hereditary cancers and eleven related syndromes.

Established in 2014, Prenetics Global Limited now serves as an industry leader from its home base situated in Quarry Bay, Hong Kong.

Sector:Health Care
Country:Hong Kong SAR China
Industry:Health Care Providers & Services
Address:Unit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay, Hong Kong
Employees:285
Website:ir.prenetics.com

Pros

Expanding market for preventative health solutions

Proprietary genetic testing intellectual property

Scalable direct-to-consumer distribution model

Diversified diagnostic product portfolio

Accumulation of genetic data for insights

Cons

Intense regulatory oversight in diagnostics

High research and development capital intensity

Consumer demand sensitivity to economic cycles

Data privacy and cybersecurity compliance burden

Competition from established diagnostic laboratories

Company	AI Score	Compare
NEONeogenomics Inc

Company	AI Score	Compare
NEONeogenomics Inc

PRE Stock AI Analysis